Tag: blood transfusion diagnostics market share

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What Growth Rate Can Be Expected in the Blood Transfusion Diagnostics Market from 2024 Through 2033?

The size of the blood transfusion diagnostics market has seen rapid expansion in the past few years. The expected growth is from $3.98 billion in 2023 to $4.42 billion in 2024, with a compound annual growth rate (CAGR) of 11.1%. The growth during the historic period can be linked to a rise in blood transfusions, newly emerging pathogens, a growing aging population, a surge in the demand for quick blood transfusion diagnostics, an increase in chronic disease prevalence, and heightened blood demand.

In the coming years, the blood transfusion diagnostics market is projected to experience substantial growth, expected to reach $6.04 billion by 2028, indicating a compound annual growth rate (CAGR) of 8.1%. Factors driving this growth in the forecast period include an increase in the desire for precision medicine, more investments in blood transfusion infrastructure, a rise in demand for molecular blood transfusions, emerging infectious diseases, and concerns about blood safety. Key trends anticipated during the forecast period comprise advancements in diagnostics, point-of-care testing, the use of automation and robotics, the introduction of nucleic acid testing (nat), digital integration, broader pathogen panels, and cutting-edge testing technologies.

Claim Your Free Sample of the Global Blood Transfusion Diagnostics Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=2494&type=smp

What Dynamics Are Shaping the Growth of the blood transfusion diagnostics Market?

Blood transfusion diagnostics are necessary for patients who are undergoing surgical operations as they help replenish blood lost during these procedures. They serve as a screen for the blood prior to being transmitted to the patient, thus reducing the probability of spreading infectious diseases. Around 310 million surgeries are carried out worldwide every year, according to a publication by the US National Library of Medicine, National Institutes of Health. Consequently, there is a constantly growing demand for blood transfusion diagnostics.

What Are the Essential Segments of the Blood Transfusion Diagnostics Market?

1) By Type: Instruments and Kits, Reagents, Other Types

2) By Technology: Western Blot, ELISA, Nucleic Acid Amplification, Fluorescence assay, Rapid Test

3) By Application: Blood Grouping, Disease Screening

4) By End User: Hospitals, Diagnostic Laboratories, Blood Banks, Plasma Fractionation Companies

What Are the Defining Trends in the Evolving Blood Transfusion Diagnostics Market?

The escalating demand for enhanced diagnostic procedures coupled with the rising incidence of infectious diseases linked to pathogens like bacteria and viruses is fuelling the preference for nucleic acid amplification testing (NAAT/NAT). This test is being increasingly utilized to enhance blood safety, optimize efficiency, and truncate the result’s waiting time. NAT is a method that aids in identifying specific nucleic acid, viruses, or bacteria acting as pathogens in blood, urine, or tissues. Known for its high sensitivity and specificity for viral nucleic acids, NAT amplifies targeted viral DNA regions, allowing earlier detection than traditional methods, thereby limiting the duration of infectious diseases. For instance, an agreement was reached where XCRP Diagnostic Inc. licensed its Xtreme Chain Reaction Nucleic Acid Amplification Technology to Luminex Corporations. Consequently, Luminex secured exclusive rights to employ XCR Diagnostic’s NAAT technology in their forthcoming molecular diagnostic portfolio.

Order Now for Fast Delivery of Your Blood Transfusion Diagnostics Market Report!

https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

Which Regions Are Emerging as Leaders in the Blood Transfusion Diagnostics Market?

North America was the largest region in the blood transfusion diagnostics market in 2023. Western Europe was the second-largest region in the blood transfusion diagnostics industry. The regions covered in the blood transfusion diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The Blood Transfusion Diagnostics Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the blood transfusion diagnostics market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Blood Transfusion Diagnostics Market Include

1. Blood Transfusion Diagnostics Market Executive Summary

2. Blood Transfusion Diagnostics Market Segments

3. Blood Transfusion Diagnostics Market Size And Template Market Growth Rate

4. Key Blood Transfusion Diagnostics Market Trends

5. Major Blood Transfusion Diagnostics Market Drivers

……

25. Key Mergers And Acquisitions In The Blood Transfusion Diagnostics Market

26. Top Blood Transfusion Diagnostics Companies

27. Blood Transfusion Diagnostics Market Opportunities And Strategies

28. Blood Transfusion Diagnostics Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

Blood And Blood Components Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blood-and-blood-components-global-market-report

Blood Group Typing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blood-group-typing-global-market-report

Dialysis Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/dialysis-devices-and-equipment-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

The blood transfusion diagnostics market has witnessed rapid expansion in recent years, driven by various factors contributing to its robust growth. Let’s explore the trends, innovations, and market dynamics shaping the landscape of blood transfusion diagnostics.

Rising Prevalence Of Blood-Related Diseases Fuels Market Growth

• Disease Prevalence: The increasing incidence of blood-related diseases such as leukemia and clotting disorders underscores the importance of efficient blood transfusion diagnostics.
• Early Detection: Blood transfusion diagnostics aid in early disease detection and ensure the safe management of blood-related disorders, reducing risks for patients.

Key Players Driving Innovation and Market Growth

• Industry Leaders: Major companies like Grifols S.A., Bio-Rad Laboratories Inc., Abbott Laboratories, and Ortho Clinical Diagnostics play pivotal roles in driving advancements and expanding market presence.
• Innovative Solutions: Companies are developing advanced serological tests like the Immediate Spin Crossmatch (ISXM) test to enhance blood transfusion safety and efficiency.

Read More On The Blood Transfusion Diagnostics Market Report 2024 – https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

Ortho Clinical Diagnostics Enhances Blood Transfusion Safety

• ISXM Test: Ortho Clinical Diagnostics introduced the Immediate Spin Crossmatch (ISXM) test to detect ABO blood type incompatibility, ensuring compatibility between donor red blood cells and recipient serum/plasma.
• Technological Advancements: The ISXM test, available on ORTHO VISION and ORTHO VISION MAX Analyzers, represents a significant advancement in blood transfusion diagnostics technology.

Market Segmentation and Regional Dominance

• Segmentation: The blood transfusion diagnostics market is segmented by type (Instruments and Kits, Reagents, Other Types), technology (Western Blot, ELISA, Nucleic Acid Amplification, etc.), application, and end-user.
• Regional Influence: North America emerged as the largest region in the blood transfusion diagnostics market in 2023, reflecting its significant contributions to market growth and innovation.

Future Trends and Growth Projections

• Market Projections: The market is expected to reach $6.04 billion by 2028, driven by rising demand for precision medicine and growing investments in blood transfusion infrastructure.
• Innovative Trends: Advancements in diagnostics, point-of-care testing, automation, nucleic acid testing, and digital integration are expected to shape the future of blood transfusion diagnostics.

In conclusion, the blood transfusion diagnostics market is witnessing rapid expansion fueled by the rising prevalence of blood-related diseases, technological innovations, and the concerted efforts of key industry players. As the demand for efficient and reliable blood transfusion diagnostics continues to grow, the market is poised to embrace novel solutions and technologies, ensuring enhanced patient safety and healthcare outcomes globally.

Request for A Sample Of The Global Blood Transfusion Diagnostics Market Report:
https://www.thebusinessresearchcompany.com/sample_request?id=2494&type=smp